These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13935926)

  • 1. Successful use of mydocalm in peripheral arterial disease.
    MOLNAR L
    Ther Hung; 1962; 10():10-2. PubMed ID: 13935926
    [No Abstract]   [Full Text] [Related]  

  • 2. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
    LINKE H
    Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mydocalm, a new drug to relax spastic muscles in neurological diseases].
    LEHOCZKY T
    Ther Hung; 1961; 9():10-3. PubMed ID: 13929385
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylactic reactions to tolperisone (Mydocalm).
    Ribi C; Vermeulen C; Hauser C
    Swiss Med Wkly; 2003 Jun; 133(25-26):369-71. PubMed ID: 12947534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral vascular diseases and generalized scleroderma treated with mydocalm].
    Lukasiak B; Szczepański A; Rózański J; Wnorowski J
    Przegl Dermatol; 1973; 60(3):383-9. PubMed ID: 4748081
    [No Abstract]   [Full Text] [Related]  

  • 6. [MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
    BLONDEL F; COULEON M; COULEON H; ANNE L; CLERC G; COULOMBIER J; TRENQUALYEJP DE
    Ann Med Psychol (Paris); 1964 Dec; 122():755-8. PubMed ID: 14252013
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical study of a musculotropic vasodilating compound.
    SHAFTEL HE; SAMUELS S; PADERNACHT E
    Angiology; 1961 Sep; 12():423-6. PubMed ID: 13750570
    [No Abstract]   [Full Text] [Related]  

  • 8. Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin.
    Abrányi I
    Ther Hung; 1988; 36(2):56-61. PubMed ID: 3201387
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of vascular diseases with Mydocalm.
    Sztankay C
    Ther Hung; 1970; 18(3):121-4. PubMed ID: 5496813
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations with Mydocalm in angiological practice.
    Balogh A
    Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mydocalm causing anaphylaxis].
    Kwaśniewski A; Korbuszewska-Gontarz B; Mika S
    Pneumonol Alergol Pol; 2003; 71(5-6):250-2. PubMed ID: 14587432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical study of tolperisone, a muscle relaxant agent, by circular dichroism and ultraviolet spectroscopy.
    Zsila F; Hollósi M; Gergely A
    Chirality; 2000 Nov; 12(10):720-6. PubMed ID: 11054830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations with higher Mydocalm doses in outpatients of the surgical department.
    Huber L
    Ther Hung; 1986; 34(4):243-7. PubMed ID: 3449980
    [No Abstract]   [Full Text] [Related]  

  • 14. [The administration of mydocalm and donalgin in vertebro-radicular syndromes].
    Ovanesian GA; Martirosian GP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(11):47-8. PubMed ID: 10578538
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of "Muscarum" in temporomandibular joint syndrome].
    Shirakawa M; Uzawa S; Shizume M; Wade H; Nakajima T
    Shikai Tenbo; 1979; 53(3):517-20. PubMed ID: 295974
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic treatment of neurolathyrism with tolperisone HCL (Mydocalm): a randomized double blind and placebo controlled drug trial.
    Melka A; Tekle-Haimanot R; Lambien F
    Ethiop Med J; 1997 Apr; 35(2):77-91. PubMed ID: 9577009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of muscle relaxants and occlusal bite plate in treatment of temporomandibular joint dysfunction syndrome.
    Amir A; Sakuda M; Miyazaki T
    J Osaka Univ Dent Sch; 1978 Dec; 18():1-10. PubMed ID: 296264
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of efficacy and safety of mydocalm in the early rehabilitation of stroke].
    Kovalchuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):35-40. PubMed ID: 23739438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations with high Mydocalm doses in the treatment of internal diseases.
    Udvardi G
    Ther Hung; 1987; 35(1):23-7. PubMed ID: 3438860
    [No Abstract]   [Full Text] [Related]  

  • 20. [The experience of mydocalm application for the arrest of neuroleptic syndrome].
    Kolotilin GF; Abramenko SG; Iakovlev AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):52. PubMed ID: 10629933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.